Pharmaceutical

As the Trump administration works to implement a “most-favored nation” policy, Lilly said it’s “rebalancing” prices to “align” costs across different...

Merck has begun the 8% reduction of its workforce—an initiative that the company revealed two weeks ago—with the dismissal of 58 employees at its head...

VML Health has stepped up its work on advanced technology, data and AI-enabled strategies by naming Jason Reese global chief transformation officer.

Vor Bio’s big bet on RemeGen’s autoimmune asset telitacicept appears well placed after the drug—already approved across three conditions overseas—deli...

The National Advertising Division has sided with Genomic Health in a challenge the Exact Sciences subsidiary brought against fellow cancer diagnostics...

Generic versions of CSL’s iron replacement therapy Venofer have arrived in the U.S. after Viatris had initially touted a potential launch in 2022.

As it continues development of its rademikibart for asthma and other inflammatory diseases, Connect Biopharma is teaming up with former pro football p...

The expansion is part of AbbVie’s larger $10 billion commitment to U.S. investment in the face of Trump’s tariff threats.

While Vor provided no details on the results, the company is now evaluating a global trial of the drug in the chronic immune condition.

Nationwide competition to pilot new models of obesity support Nationwide competition to pilot new models of obesity support